MultiPlan Financials

MPLN Stock  USD 10.03  0.98  8.90%   
Based on the analysis of MultiPlan's profitability, liquidity, and operating efficiency, MultiPlan may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, MultiPlan's Capital Lease Obligations is very stable compared to the past year. As of the 23rd of October 2024, Other Current Assets is likely to grow to about 37.3 M, while Total Current Liabilities is likely to drop about 137.1 M. Key indicators impacting MultiPlan's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio2.712.6626
Fairly Up
Slightly volatile
Current Ratio1.441.1611
Fairly Up
Pretty Stable
The financial analysis of MultiPlan is a critical element in measuring its lifeblood. Investors should not minimize MultiPlan's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

(96.28 Million)

  
Understanding current and past MultiPlan Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of MultiPlan's financial statements are interrelated, with each one affecting the others. For example, an increase in MultiPlan's assets may result in an increase in income on the income statement.

MultiPlan Stock Summary

MultiPlan competes with FOXO Technologies, Heartbeam, EUDA Health, Nutex Health, and Healthcare Triangle. MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York. Multiplan Corp operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. It employs 2500 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
ISINUS62548M1009
CUSIP62548M100 17144C104 17144C203
LocationNew York; U.S.A
Business Address115 Fifth Avenue,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.multiplan.us
Phone212 780 2000
CurrencyUSD - US Dollar

MultiPlan Key Financial Ratios

MultiPlan Key Balance Sheet Accounts

201920202021202220232024 (projected)
Other Liab869.2M1.0B828.0M642.0M577.8M692.9M
Net Tangible Assets(6.2B)(5.5B)(5.3B)(4.9B)(5.6B)(5.9B)
Retained Earnings637.6M107.9M225.1M(347.8M)(499.3M)(474.3M)
Accounts Payable9.6M15.3M13.0M13.3M19.6M15.0M
Other Assets8.2M14.2M9.7M21.9M25.2M13.2M
Net Receivables77.1M63.2M99.9M78.9M76.6M87.6M
Total Current Assets115.6M208.9M319.3M446.7M193.6M254.8M

MultiPlan Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense376.3M335.6M267.5M303.4M333.2M314.2M
Ebit368.2M(105.2M)386.2M303.0M173.4M219.1M
Income Tax Expense799K(26.3M)33.4M12.2M(15.4M)(16.1M)
Tax Provision799K(26.3M)33.4M12.2M(12.8M)(12.2M)
Net Interest Income(376.2M)(335.4M)(267.4M)(299.9M)(322.7M)(338.8M)
Interest Income196K288K30K3.5M9.7M10.1M
Total Revenue982.9M937.8M1.1B1.1B961.5M1.1B
Gross Profit833.3M619.1M942.3M875.6M306.0M595.7M
Operating Income368.2M(105.2M)386.1M303.0M173.4M207.1M
Ebitda758.3M298.5M798.2M718.6M599.2M531.6M
Cost Of Revenue149.6M318.7M175.3M204.1M655.5M688.3M
Income Before Tax10.5M(556.0M)135.5M(560.7M)(107.1M)(112.4M)
Net Income9.7M(529.6M)102.1M(572.9M)(91.7M)(96.3M)

MultiPlan Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash16.8M104.9M61.6M152.2M(259.1M)(246.1M)
Net Borrowings(201.1M)(619.4M)(10.9M)(113.2M)(101.9M)(96.8M)
Depreciation389.9M403.7M412.1M415.7M425.8M443.2M
Capital Expenditures66.4M70.8M84.6M89.7M108.9M85.6M
Net Income9.7M(529.6M)102.1M(572.9M)(91.7M)(87.1M)
End Period Cash Flow21.8M126.8M188.4M340.6M81.5M123.4M
Change To Netincome(131.2M)464.2M(65.4M)541.6M622.9M654.0M
Investments(66.4M)(210.8M)5.6M(104.4M)(244.0M)(231.8M)
Free Cash Flow217.9M306.6M320.1M282.6M62.9M59.7M
Other Non Cash Items(4.9M)112.3M(1.5M)571.9M(44.4M)(42.2M)

MultiPlan Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining MultiPlan's current stock value. Our valuation model uses many indicators to compare MultiPlan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MultiPlan competition to find correlations between indicators driving MultiPlan's intrinsic value. More Info.
MultiPlan is rated below average in return on equity category among its peers. It is regarded third in return on asset category among its peers . At this time, MultiPlan's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MultiPlan's earnings, one of the primary drivers of an investment's value.

MultiPlan Systematic Risk

MultiPlan's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. MultiPlan volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on MultiPlan correlated with the market. If Beta is less than 0 MultiPlan generally moves in the opposite direction as compared to the market. If MultiPlan Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one MultiPlan is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of MultiPlan is generally in the same direction as the market. If Beta > 1 MultiPlan moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in MultiPlan Stock are looking for potential investment opportunities by analyzing not only static indicators but also various MultiPlan's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of MultiPlan growth as a starting point in their analysis.

Price Earnings To Growth Ratio

5.04

At this time, MultiPlan's Price Earnings To Growth Ratio is very stable compared to the past year.

MultiPlan October 23, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of MultiPlan help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MultiPlan. We use our internally-developed statistical techniques to arrive at the intrinsic value of MultiPlan based on widely used predictive technical indicators. In general, we focus on analyzing MultiPlan Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MultiPlan's daily price indicators and compare them against related drivers.
When determining whether MultiPlan offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MultiPlan's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Multiplan Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Multiplan Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MultiPlan. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
To learn how to invest in MultiPlan Stock, please use our How to Invest in MultiPlan guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MultiPlan. If investors know MultiPlan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MultiPlan listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.99)
Earnings Share
(72.40)
Revenue Per Share
59.002
Quarterly Revenue Growth
(0.02)
Return On Assets
0.0139
The market value of MultiPlan is measured differently than its book value, which is the value of MultiPlan that is recorded on the company's balance sheet. Investors also form their own opinion of MultiPlan's value that differs from its market value or its book value, called intrinsic value, which is MultiPlan's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MultiPlan's market value can be influenced by many factors that don't directly affect MultiPlan's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MultiPlan's value and its price as these two are different measures arrived at by different means. Investors typically determine if MultiPlan is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MultiPlan's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.